Search Results - "Kinkel, R. Philip"

Refine Results
  1. 1
  2. 2

    Internet portal use in an academic multiple sclerosis center by Nielsen, A Scott, Halamka, John D, Kinkel, R Philip

    “…To evaluate the use of a secure internet portal in an academic Multiple Sclerosis (MS) Center. Retrospective case-control chart review of 240 patients during…”
    Get full text
    Journal Article
  3. 3

    Spontaneous regression of primary autoreactivity during chronic progression of experimental autoimmune encephalomyelitis and multiple sclerosis by Tuohy, V K, Yu, M, Yin, L, Kawczak, J A, Kinkel, R P

    Published in The Journal of experimental medicine (05-04-1999)
    “…Experimental autoimmune encephalomyelitis (EAE) is a widely used animal model for multiple sclerosis (MS). EAE is typically initiated by CD4(+) T helper cell…”
    Get full text
    Journal Article
  4. 4

    Focal cortical lesion detection in multiple sclerosis: 3 tesla DIR versus 7 tesla FLASH-T2 by Nielsen, A. Scott, Kinkel, R. Philip, Tinelli, Emanuele, Benner, Thomas, Cohen-Adad, Julien, Mainero, Caterina

    Published in Journal of magnetic resonance imaging (01-03-2012)
    “…Purpose: To evaluate the inter‐rater agreement of cortical lesion detection using 7 Tesla (T) FLASH‐T2* and 3T DIR sequences. Materials and Methods: Twenty‐six…”
    Get full text
    Journal Article
  5. 5

    Asymptomatic Reactivation of JC Virus in Patients Treated with Natalizumab by Chen, Yiping, Bord, Evelyn, Tompkins, Troy, Miller, Janice, Tan, Chen S, Kinkel, R. Philip, Stein, Marion C, Viscidi, Raphael P, Ngo, Long H, Koralnik, Igor J

    Published in The New England journal of medicine (10-09-2009)
    “…Progressive multifocal leukoencephalopathy (PML) is a rare complication of natalizumab treatment and is caused by the JC virus. In this study of 19 patients…”
    Get full text
    Journal Article
  6. 6

    Patterns of mobility aid use among working-age persons with multiple sclerosis living in the community in the United States by Iezzoni, Lisa I., M.D., M.Sc, Rao, Sowmya R., Ph.D, Kinkel, R. Philip, M.D

    Published in Disability and health journal (01-04-2009)
    “…Abstract Background Difficulty walking is the most visible sign of disability among persons with multiple sclerosis (MS). However, little is known about…”
    Get full text
    Journal Article
  7. 7
  8. 8

    JC virus reactivation during prolonged natalizumab monotherapy for multiple sclerosis by Chalkias, Spyridon, Dang, Xin, Bord, Evelyn, Stein, Marion C., Kinkel, R. Philip, Sloane, Jacob A., Donnelly, Maureen, Ionete, Carolina, Houtchens, Maria K., Buckle, Guy J., Batson, Stephanie, Koralnik, Igor J.

    Published in Annals of neurology (01-06-2014)
    “…Objective To determine the prevalence of JC virus (JCV) reactivation and JCV‐specific cellular immune response during prolonged natalizumab treatment for…”
    Get full text
    Journal Article
  9. 9

    Immune reconstitution inflammatory syndrome in patients with multiple sclerosis following cessation of natalizumab therapy by Miravalle, Augusto, Jensen, Rikke, Kinkel, R Philip

    Published in Archives of neurology (Chicago) (01-02-2011)
    “…To assess clinical consequences of temporary natalizumab dosage suspension. Prospective cohort study. Multiple sclerosis (MS) center at an academic medical…”
    Get more information
    Journal Article
  10. 10

    Disease-related determinants of quality of life 10 years after clinically isolated syndrome by Kinkel, R Philip, Laforet, Genevieve, You, Xiaojun

    Published in International journal of MS care (01-01-2015)
    “…The main clinical determinants of quality of life (QOL) 5 years after clinically isolated syndrome (CIS) are Expanded Disability Status Scale (EDSS) score and…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Use and cost of disease-modifying therapies by Sonya Slifka Study participants: has anything really changed since 2000 and 2009? by Minden, Sarah L, Kinkel, R Philip, Machado, Helene T, Levin, Jonathan S, Rosenthal, Meredith B, Iezzoni, Lisa I

    “…Background Disease-modifying therapies benefit individuals with relapsing forms of multiple sclerosis, but their utility remains unclear for those without…”
    Get full text
    Journal Article
  13. 13

    Experiences acquiring and using mobility aids among working-age persons with multiple sclerosis living in communities in the United States by Iezzoni, Lisa I, Rao, Sowmya R, Kinkel, R Philip

    “…To examine patterns of mobility aid ownership and use among working-age United States residents with multiple sclerosis. A 30-min telephone survey in mid-2007…”
    Get full text
    Journal Article
  14. 14

    Asymptomatic Reactivation of JC Virus in Patients Treated with Natalizumab by Gorelik, Leonid, Goelz, Susan, Sandrock, Alfred W

    Published in The New England journal of medicine (17-12-2009)
    “…To the Editor: Chen and colleagues (Sept. 10 issue) 1 describe an increased prevalence of JC virus DNA in 19 patients with multiple sclerosis after 12 to 18…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Anti-Tumor Necrosis Factor Alpha-Associated Multiple Sclerosis by Titelbaum, David S, Degenhardt, Alexandra, Kinkel, R. Philip

    Published in American Journal of Neuroradiology (01-06-2005)
    “…A case of multiple sclerosis presenting during anti-tumor necrosis factor treatment for rheumatoid arthritis is discussed. This association has been reported…”
    Get full text
    Journal Article
  17. 17
  18. 18

    The epitope spreading cascade during progression of experimental autoimmune encephalomyelitis and multiple sclerosis by Tuohy, Vincent K., Yu, Min, Yin, Ling, Kawczak, Julie A., Johnson, Justin M., Mathisen, Peter M., Weinstock-Guttnnan, Bianca, Kinkel, R. Philip

    Published in Immunological reviews (01-08-1998)
    “…We have made the following observations regarding self‐recognition during the development and progression of murine experimental autoimmune encephalomyelitis…”
    Get full text
    Journal Article
  19. 19

    Health-related quality of life assessment in multiple sclerosis by Miller, Deborah M, Kinkel, R Philip

    Published in Reviews in neurological diseases (2008)
    “…The goal of evidence-based medicine in the treatment of conditions that produce morbidity but have a minimal impact on mortality is arguably to reduce disease…”
    Get full text
    Journal Article
  20. 20

    Acute paraplegia with vanishing white matter lesions by Jensen, Rikke M, Kinkel, R Philip

    Published in Reviews in neurological diseases (2008)
    “…Young adults presenting with an acute myelopathy often represent a diagnostic challenge. We present the case of a 20-year-old man who demonstrated many of the…”
    Get full text
    Journal Article